| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11060-012-0856-X |
| P698 | PubMed publication ID | 22484910 |
| P2093 | author name string | Håkan Hedman | |
| Thomas Brännström | |||
| Hannu Haapasalo | |||
| Mine Eray | |||
| Ulrika Andersson | |||
| Soma Ghasimi | |||
| Katariina Korhonen | |||
| P2860 | cites work | LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation | Q24563349 |
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Characterization and tissue-specific expression of human LRIG2. | Q33202937 | ||
| Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study | Q33246038 | ||
| Cloning, characterization, and expression of human LIG1. | Q33952106 | ||
| Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas | Q34001907 | ||
| Epidemiology and etiology of meningioma | Q34154936 | ||
| LRIG1 protein in human cells and tissues | Q34189486 | ||
| Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study | Q34342499 | ||
| The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases | Q34345557 | ||
| Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer | Q35386137 | ||
| LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? | Q36713685 | ||
| Radiation-induced meningioma | Q37151379 | ||
| Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma | Q37761398 | ||
| Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors | Q40305809 | ||
| Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas | Q40554806 | ||
| Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland | Q42929636 | ||
| Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. | Q43219758 | ||
| Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells | Q43287031 | ||
| Craniotomy for resection of meningioma in the elderly: a multicentre, prospective analysis from the National Surgical Quality Improvement Program | Q43517721 | ||
| Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue | Q46752199 | ||
| The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea | Q47328238 | ||
| Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients | Q48284475 | ||
| Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer | Q48447442 | ||
| Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival | Q48837559 | ||
| Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. | Q51804977 | ||
| LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases. | Q52564093 | ||
| Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1 | Q55463661 | ||
| Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. | Q55473202 | ||
| LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer | Q60651155 | ||
| Radiation-induced meningioma: a descriptive study of 253 cases | Q78568008 | ||
| Redistribution of LRIG proteins in psoriasis | Q79976891 | ||
| LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking | Q80598286 | ||
| Genotyping of patients with sporadic and radiation-associated meningiomas | Q81638921 | ||
| LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix | Q84419341 | ||
| P433 | issue | 3 | |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 435-441 | |
| P577 | publication date | 2012-04-08 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression | |
| P478 | volume | 108 |
| Q36437261 | Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth |
| Q37328598 | Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer |
| Q38098922 | Genetics of human congenital urinary bladder disease |
| Q35626430 | LRIG and cancer prognosis |
| Q38096295 | LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor |
| Q33844052 | LRIG2 expression and prognosis in non-small cell lung cancer |
| Q28283130 | LRIG2 mutations cause urofacial syndrome |
| Q99238334 | Recurrence/Regrowth in Grade I Meningioma: How to Predict? |
Search more.